2010
DOI: 10.1111/j.1600-0404.2009.01257.x
|View full text |Cite
|
Sign up to set email alerts
|

Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up

Abstract: Levetiracetam is an effective and well-tolerated option for long-term treatment of epilepsy in adults.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
1
4

Year Published

2012
2012
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 22 publications
1
5
1
4
Order By: Relevance
“…Discontinuation for lack of efficacy was most common with γ‐aminobutyric acidergic drugs, whereas discontinuation for adverse events was mostly seen with topiramate, phenytoin, carbamazepine, and levetiracetam, in decreasing order. These findings are not unexpected, although the rates differ from those of other reports on account of differing prescribing patterns and different populations at risk.…”
Section: Discussioncontrasting
confidence: 83%
“…Discontinuation for lack of efficacy was most common with γ‐aminobutyric acidergic drugs, whereas discontinuation for adverse events was mostly seen with topiramate, phenytoin, carbamazepine, and levetiracetam, in decreasing order. These findings are not unexpected, although the rates differ from those of other reports on account of differing prescribing patterns and different populations at risk.…”
Section: Discussioncontrasting
confidence: 83%
“…The studies conducted for 6 months indicated that levetiracetam remains effective for migraine prophylaxis for the en- TA B L E 2 Recommended dosing schedule of levetiracetam for migraine prophylaxis [21][22][23][24][25][26][27][28] mood disorders such as irritability, which often were transient or could be improved by decreasing the dose. 32,33 Patients may find these adverse effects to be an acceptable risk if long-term efficacy is established.…”
Section: Levetiracetam For Chronic Migraine In Adult Patientsmentioning
confidence: 99%
“…Однако на фоне приема леветирацетама наруше-ния поведения встречаются с частотой 10-51 % и включают также тревогу, эмоциональную лабиль-ность, невротические реакции, апатию, депрессию [20,53,58,69,72,89]. Леветирацетам может вызывать или усиливать возбудимость, раздражительность, ко-лебания настроения и агрессивность [25].…”
Section: безопасность и переносимость леветирацетамаunclassified
“…В зарубежной литературе при приеме леветирацетама описаны случаи усиления возбудимо-сти, раздражительности, колебаний настроения и пе-риодической агрессивности [20,25,58,72,81,89]. Важно иметь в виду, что усиление раздражительности и возбудимости может усиливать проявления СДВГ у больных эпилепсией [9].…”
Section: безопасность и переносимость леветирацетамаunclassified